See every side of every news story
Get Started
SubscribeLogin
Jeffrey Epstein
Artificial Intelligence
Social Media
Donald Trump
Natural Disasters
Education
Floods
Republican Party
Israel-Hamas Conflict
Soccer
US Politics
Basketball
ophthalmologytimes.com image

News from ophthalmologytimes.com

We’ve assigned a media bias rating of unknown to ophthalmologytimes.com. You can read more about our methodology here.

Information about ophthalmologytimes.com

Where is ophthalmologytimes.com located?ophthalmologytimes.com's Website

Media Bias Ratings

Do you diasgree?
Edit bias
Learn more about Media Bias Ratings.

Factuality

Learn more about  Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about  Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top ophthalmologytimes.com News

Hims & Hers to Bring Generic Semaglutide to Canada
Health Canada · Canada

Hims & Hers to Bring Generic Semaglutide to Canada

49% Center coverage: 8 sources
The Hims & Hers wellness platform announced Wednesday it will soon offer a generic version of the weight loss drug semaglutide in Canada as Novo Nordisk's patent on its branded version, known as Wegovy, will soon expire.See the Story
Nanoscope Begins Rolling Submission of Biologics License Application for RP Gene Therapy
United States · United States

Nanoscope Begins Rolling Submission of Biologics License Application for RP Gene Therapy

100% Center coverage: 2 sources
 Nanoscope Therapeutics submitted the first modules of a biologics license application for MCO-010, an investigational gene therapy to treat severe vision loss in retinitis pigmentosa, to the FDA, according to a press release.See the Story
FDA fast-tracks Sanofi's gene therapy for eye disease GA
AMD · United States

FDA fast-tracks Sanofi's gene therapy for eye disease GA

100% Center coverage: 1 sources
Sanofi has been granted a speedy review from the FDA for a gene therapy for geographic atrophy, a major cause of blindnessSee the Story

Apellis Announces Five Abstracts Accepted for Oral Presentation at the American Society of ...

100% Center coverage: 1 sources
WALTHAM, Mass., July 15, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that five abstracts were accepted for oral presentation at the American Society of Retina Specialists (ASRS) Annual Scientific Meeting to be held July 30 -…San Francisco, California · San FranciscoSee the Story

Harrow enters into agreement with Samsung Bioe for commercial rights to its ophthalmology biosimilar portfolio

Included in the agreement are ranibizumab-nuna 0.05 mL injection (BYOOVIZ), referencing LUCENTIS (ranibizumab), and aflibercept-yszy 0.05 mL injection (OPUVIZ), referencing EYLEA (aflibercept).Read Article

Study links secondhand smoke exposure to increased myopia risk in children

A Chinese study reveals that secondhand smoke exposure significantly increases the risk of early-onset myopia in childrenChina · ChinaRead Article

New RainDrop Dispenser Aid aims to simplify use of single-use eye drops

The tool is designed to help with the application of mono-dose, dry eye eyedrop vials more easily and accurately.Read Article

Survey data shows trends for AMD and DME treatments and future prospects

The survey shows the evolving landscape of nAMD and DME treatments, highlighting physician preferences, payer influences, and the promise of gene therapy advancements.AMDRead Article

Team engineers a microbial platform for efficient lutein production

100% Center coverage: 1 sources
A research group at KAIST has successfully engineered a microbial strain capable of producing lutein at industrially relevant levels. The team, led by Distinguished Professor Sang Yup Lee from the Department of Chemical and Biomolecular Engineering, developed a novel C. glutamicum strain using systems metabolic engineering strategies to overcome the limitations of previous microbial lutein production efforts.Innovation · South KoreaSee the Story

Krystal Biotech doses first patient in EMERALD-1 phase 1/2 trial for neurotrophic keratitis

Krystal Biotech initiates EMERALD-1 trial for KB801, a redosable eye drop gene therapy.Read Article

MidWest Eye Center Among First in Midwest to Adopt New Noncontact Laser for Glaucoma

Alcon’s Voyager is a fully automated, noncontact treatment approach that delivers 120 laser pulses through the limbus of the trabecular meshwork.United States · United StatesSee the Story

Breaking News Topics Related to ophthalmologytimes.com

Utah icon

Utah

Salt Lake County icon

Salt Lake County

AMD icon

AMD

Salt Lake City icon

Salt Lake City

Maryland icon

Maryland

United States icon

United States

News
For You
SearchBlindspotLocal